ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 20 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,505,000 | -13.1% | 1,870,000 | 0.0% | 1.53% | +4.2% |
| Q4 2015 | $1,731,000 | -20.9% | 1,870,000 | -15.8% | 1.47% | -11.9% |
| Q3 2015 | $2,188,000 | +139.9% | 2,220,000 | +208.3% | 1.67% | +194.5% |
| Q2 2015 | $912,000 | -79.2% | 720,000 | -79.4% | 0.57% | -74.0% |
| Q1 2015 | $4,395,000 | +34.4% | 3,500,000 | 0.0% | 2.17% | +35.3% |
| Q4 2014 | $3,270,000 | +5.6% | 3,500,000 | 0.0% | 1.61% | +6.4% |
| Q3 2014 | $3,097,000 | -31.7% | 3,500,000 | -22.2% | 1.51% | -33.2% |
| Q2 2014 | $4,535,000 | -19.9% | 4,500,000 | -18.2% | 2.26% | +3.6% |
| Q1 2014 | $5,662,000 | +11.2% | 5,500,000 | +12.2% | 2.18% | +57.3% |
| Q4 2013 | $5,090,000 | -26.1% | 4,900,000 | -18.3% | 1.39% | -11.5% |
| Q3 2013 | $6,889,000 | +87.0% | 6,000,000 | +55.8% | 1.57% | +87.6% |
| Q2 2013 | $3,684,000 | – | 3,850,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |